Latest Capital Structure News

Nova Minerals has secured ASIC registration of its Scheme Booklet for re-domiciling to the US, alongside amendments to warrant terms that triple warrant exchange ratios ahead of the move.

Syrah Resources has closed its retail entitlement offer, securing A$61 million and pushing total equity raised to A$104 million. AustralianSuper’s stake will approach half the company as Syrah prepares to fund key projects and advance strategic funding talks.

Metro Mining’s latest JORC update reveals a 69.6 million wet tonne Ore Reserve at Bauxite Hills, reflecting 8.1 million tonnes mined in 2025 with no new resource additions. The high-grade bauxite operation continues as a direct shipping ore mine amid rising silica content concerns.

Toro Energy has secured an ASX waiver allowing it to cancel 4.4 million unlisted options for cash without shareholder approval, clearing a key procedural hurdle in its pending acquisition by IsoEnergy.

KMD Brands has wrapped up a fully underwritten entitlement offer and placement, raising NZ$65.3 million to reduce net debt and shore up its balance sheet ahead of executing its growth plans.

Metro Mining Limited (ASX:MMI) is set to reduce its share count drastically through a 20-for-1 consolidation, pending shareholder approval at the upcoming AGM. This move will slash its ordinary shares from over 6 billion to just over 300 million, reshaping its capital structure.

Kalamazoo Resources reported a robust cash balance of AUD 8.8 million at quarter end, underpinned by a significant equity raise that offsets ongoing exploration and administrative outflows. The company’s funding runway extends beyond three quarters, positioning it to advance its Ashburton Gold Project drilling activities.

VHM Limited has secured A$5 million through a fully underwritten placement priced at A$0.26 per share, funding critical early engineering and procurement ahead of a mid-2026 final investment decision for its Goschen Rare Earth and Mineral Sands Project.

Mineral Resources has priced a US$1.3 billion senior unsecured notes offering to refinance higher-cost debt, reduce annual finance expenses by $48 million, and extend its weighted average debt maturity from 3.1 to 5 years.

Nutritional Growth Solutions (ASX: NGS) has completed a major operational reset, achieving normalised profitability, eliminating all debt, and replenishing inventory to support renewed growth.

MA Credit Income Trust has approved an on-market buy-back of its units, adding a flexible tool to its capital management arsenal amid evolving market conditions.

Lumos Diagnostics has secured a key FDA 510(k) clearance with CLIA waiver for its FebriDx rapid test, unlocking a US$1 billion-plus market opportunity and triggering milestone payments exceeding US$6 million. The company reported a 37% revenue jump in Q3 FY26, supported by a A$20 million placement and ongoing clinical and development projects.